| __timestamp | Amgen Inc. | Johnson & Johnson |
|---|---|---|
| Wednesday, January 1, 2014 | 4297000000 | 8494000000 |
| Thursday, January 1, 2015 | 4070000000 | 9046000000 |
| Friday, January 1, 2016 | 3840000000 | 9095000000 |
| Sunday, January 1, 2017 | 3562000000 | 10554000000 |
| Monday, January 1, 2018 | 3737000000 | 10775000000 |
| Tuesday, January 1, 2019 | 4116000000 | 11355000000 |
| Wednesday, January 1, 2020 | 4207000000 | 12340000000 |
| Friday, January 1, 2021 | 4819000000 | 14277000000 |
| Saturday, January 1, 2022 | 4434000000 | 14135000000 |
| Sunday, January 1, 2023 | 4784000000 | 15048000000 |
| Monday, January 1, 2024 | 5964000000 | 17232000000 |
Igniting the spark of knowledge
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Johnson & Johnson and Amgen Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Johnson & Johnson consistently allocated a significant portion of their budget to R&D, with a notable increase of approximately 77% from 2014 to 2023. This commitment underscores their dedication to pioneering new treatments and maintaining a competitive edge.
Conversely, Amgen Inc. exhibited a more conservative approach, with R&D expenses fluctuating modestly over the same period. Despite a dip in 2017, Amgen's R&D spending rebounded by 2023, reflecting a 12% increase from their 2014 levels. This strategic allocation highlights their focus on optimizing existing products while cautiously exploring new avenues.
These insights reveal the distinct paths these industry leaders take in their quest for innovation and market leadership.
Johnson & Johnson vs Merck & Co., Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Johnson & Johnson vs Bristol-Myers Squibb Company
Research and Development Investment: Johnson & Johnson vs Pfizer Inc.
Operational Costs Compared: SG&A Analysis of Johnson & Johnson and Amgen Inc.
Who Prioritizes Innovation? R&D Spending Compared for Johnson & Johnson and Zoetis Inc.
Research and Development Investment: Johnson & Johnson vs Catalyst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Johnson & Johnson and Celldex Therapeutics, Inc.
Comparing Innovation Spending: Amgen Inc. and Exelixis, Inc.
R&D Insights: How Amgen Inc. and Pharming Group N.V. Allocate Funds
Research and Development Expenses Breakdown: Amgen Inc. vs Soleno Therapeutics, Inc.
Comparing Innovation Spending: Amgen Inc. and Ligand Pharmaceuticals Incorporated
Amgen Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending